UToledo Researcher Receives Ohio Cancer Research Grant to Study Pancreatic Cancer’s Resistance to Treatment

Pancreatic cancer remains one of the deadliest cancers in the United States, with limited treatment options and a high rate of therapeutic resistance. A University of Toledo scientist is working to change that trajectory. Dr. Kuo-Hui Su, assistant professor in the Department of Cell and Cancer Biology, has been awarded a two-year, $80,000 grant from Ohio Cancer Research to investigate a potential new approach to treating pancreatic cancer — one that targets the disease’s ability to resist the treatments designed to fight it.